{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T02:06:29Z","timestamp":1770170789487,"version":"3.49.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82200676"],"award-info":[{"award-number":["82200676"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Science and Technology Planning Project of Putian City","award":["2023SZ3001PTXY01"],"award-info":[{"award-number":["2023SZ3001PTXY01"]}]},{"name":"the Open Project of the Putian University Key Laboratory of Translational Tumor Medicine in Fujian Province","award":["2022KF005"],"award-info":[{"award-number":["2022KF005"]}]},{"name":"College Student Innovation and Entrepreneurship Training Program of Putian University","award":["X202411498008"],"award-info":[{"award-number":["X202411498008"]}]},{"name":"the Collaborative Project Between the Hospital and College of Putian University","award":["2024106"],"award-info":[{"award-number":["2024106"]}]},{"name":"the Joint Fund Project for Scientific and Technological Innovation in the Field of Medical and Health Care in Putian","award":["2024SJYL079"],"award-info":[{"award-number":["2024SJYL079"]}]},{"name":"the Fujian Provincial Health Technology Project","award":["2024GGA089"],"award-info":[{"award-number":["2024GGA089"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03709-7","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T17:00:50Z","timestamp":1767632450000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Downregulation of USP39 in sepsis reflects immune dysfunction and offers diagnostic and prognostic value"],"prefix":"10.1186","volume":"31","author":[{"given":"Zhimin","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiancheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"1","key":"3709_CR1","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/S2213-2600(24)00257-1","volume":"13","author":"RFJ Kullberg","year":"2025","unstructured":"Kullberg RFJ, Haak BW, Chanderraj R, Prescott HC, Dickson RP, Wiersinga WJ. Empirical antibiotic therapy for sepsis: save the anaerobic microbiota. Lancet Respir Med. 2025;13(1):92\u2013100.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"3709_CR2","first-page":"412","volume":"23","author":"YC Han","year":"2023","unstructured":"Han YC, Shen ZJ, Xiang RL, Lu B, Qian H, Li JY, et al. Long noncoding RNA and mRNA expression profiles in rats with LPS-induced myocardial dysfunction. Curr Genomics. 2023;23(6):412\u201323.","journal-title":"Curr Genomics"},{"issue":"5","key":"3709_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2025.167761","volume":"1871","author":"C Parolini","year":"2025","unstructured":"Parolini C. Sepsis and high-density lipoproteins: pathophysiology and potential new therapeutic targets. Biochim Biophys Acta. 2025;1871(5):167761.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3709_CR4","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S2213-2600(23)00330-2","volume":"12","author":"S Cajander","year":"2024","unstructured":"Cajander S, Kox M, Scicluna BP, Weigand MA, Mora RA, Floh\u00e9 SB, et al. Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine. Lancet Respir Med. 2024;12(4):305\u201322.","journal-title":"Lancet Respir Med"},{"issue":"2","key":"3709_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/CNQ.0000000000000552","volume":"48","author":"T Marshall","year":"2025","unstructured":"Marshall T, Dysert K, Young M, DuMont T. Pathophysiology of sepsis. Crit Care Nurs Q. 2025;48(2):88\u201392.","journal-title":"Crit Care Nurs Q"},{"issue":"1","key":"3709_CR6","volume":"9","author":"D Liu","year":"2022","unstructured":"Liu D, Huang SY, Sun JH, Zhang HC, Cai QL, Gao C, et al. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options. Mil Med Res. 2022;9(1):56.","journal-title":"Mil Med Res"},{"issue":"1","key":"3709_CR7","first-page":"1","volume":"34","author":"J Van Damme","year":"2023","unstructured":"Van Damme J, Opdenakker G, Van Damme S, Struyf S. Antibodies as tools in cytokine discovery and usage for diagnosis and therapy of inflammatory diseases. Eur Cytokine Netw. 2023;34(1):1\u20139.","journal-title":"Eur Cytokine Netw"},{"issue":"7","key":"3709_CR8","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S2213-2600(25)00124-9","volume":"13","author":"S Deinhardt-Emmer","year":"2025","unstructured":"Deinhardt-Emmer S, Chousterman BG, Schefold JC, Floh\u00e9 SB, Skirecki T, Kox M, et al. Sepsis in patients who are immunocompromised: diagnostic challenges and future therapies. Lancet Respir Med. 2025;13(7):623\u201337.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"3709_CR9","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/s41420-023-01766-7","volume":"9","author":"M Cao","year":"2023","unstructured":"Cao M, Wang G, Xie J. Immune dysregulation in sepsis: experiences, lessons and perspectives. Cell Death Discov. 2023;9(1):465.","journal-title":"Cell Death Discov"},{"issue":"3","key":"3709_CR10","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","volume":"48","author":"J Xie","year":"2020","unstructured":"Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, et al. The epidemiology of sepsis in Chinese ICUs: a national cross-sectional survey. Crit Care Med. 2020;48(3):e209\u201318.","journal-title":"Crit Care Med"},{"issue":"9","key":"3709_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1007\/s00134-023-07127-3","volume":"49","author":"EJ Giamarellos-Bourboulis","year":"2023","unstructured":"Giamarellos-Bourboulis EJ, Zinkernagel AS, De Robertis E, Azoulay \u00c9, De Luca D. Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control. Intensive Care Med. 2023;49(9):1138\u201342.","journal-title":"Intensive Care Med"},{"key":"3709_CR12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708712","author":"L Van Wyngene","year":"2018","unstructured":"Van Wyngene L, Vandewalle J, Libert C. Reprogramming of basic metabolic pathways in microbial sepsis: therapeutic targets at last? EMBO Mol Med. 2018. https:\/\/doi.org\/10.15252\/emmm.201708712.","journal-title":"EMBO Mol Med"},{"issue":"4","key":"3709_CR13","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.molmed.2014.01.007","volume":"20","author":"JC Marshall","year":"2014","unstructured":"Marshall JC. Why have clinical trials in sepsis failed? Trends Mol Med. 2014;20(4):195\u2013203.","journal-title":"Trends Mol Med"},{"issue":"20","key":"3709_CR14","doi-asserted-by":"publisher","first-page":"9332","DOI":"10.7150\/thno.47137","volume":"10","author":"X Dai","year":"2020","unstructured":"Dai X, Lu L, Deng S, Meng J, Wan C, Huang J, et al. USP7 targeting modulates anti-tumor immune response by reprogramming tumor-associated macrophages in lung cancer. Theranostics. 2020;10(20):9332\u201347.","journal-title":"Theranostics"},{"issue":"1","key":"3709_CR15","first-page":"225","volume":"42","author":"H Gao","year":"2023","unstructured":"Gao H, Yin J, Ji C, Yu X, Xue J, Guan X, et al. Targeting ubiquitin specific proteases (USPs) in cancer immunotherapy: from basic research to preclinical application. J Exp Clin Cancer Res CR. 2023;42(1):225.","journal-title":"J Exp Clin Cancer Res CR"},{"key":"3709_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ph14090848","author":"L Cruz","year":"2021","unstructured":"Cruz L, Soares P, Correia M. Ubiquitin-specific proteases: players in cancer cellular processes. Pharmaceuticals. 2021. https:\/\/doi.org\/10.3390\/ph14090848.","journal-title":"Pharmaceuticals"},{"issue":"5","key":"3709_CR17","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4049\/jimmunol.2200603","volume":"210","author":"J Quan","year":"2023","unstructured":"Quan J, Zhao X, Xiao Y, Wu H, Di Q, Wu Z, et al. USP39 regulates NF-\u03baB-mediated inflammatory responses through deubiquitinating K48-linked I\u03baB\u03b1. J Immunol. 2023;210(5):640\u201352.","journal-title":"J Immunol"},{"issue":"11","key":"3709_CR18","first-page":"3167","volume":"205","author":"Y Peng","year":"2020","unstructured":"Peng Y, Guo J, Sun T, Fu Y, Zheng H, Dong C, et al. USP39 serves as a deubiquitinase to stabilize STAT1 and sustains type I IFN-induced antiviral immunity. J Invest Med. 2020;205(11):3167\u201378.","journal-title":"J Invest Med"},{"issue":"1","key":"3709_CR19","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/s41419-025-07796-6","volume":"16","author":"Z Xiao","year":"2025","unstructured":"Xiao Z, Wei X, Li P, Chen R, Yu Z, Liang Y, et al. Impact of N-acetyltransferase 10 on macrophage activation and inflammation-induced cardiac dysfunction. Cell Death Dis. 2025;16(1):471.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3709_CR20","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"6","key":"3709_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.32604\/chd.2023.047689","volume":"18","author":"A Zulibiya","year":"2023","unstructured":"Zulibiya A, Wen J, Yu H, Chen X, Xu L, Ma X, et al. Single-cell RNA sequencing reveals potential for endothelial-to-mesenchymal transition in tetralogy of Fallot. Congenit Heart Dis. 2023;18(6):611\u201325.","journal-title":"Congenit Heart Dis"},{"issue":"7","key":"3709_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.2174\/0109298665305114240718072029","volume":"31","author":"S Tian","year":"2024","unstructured":"Tian S, Chen M, Jing W, Meng Q, Wu J. miR-1204 positioning in 8q24.21 involved in the tumorigenesis of colorectal cancer by targeting MASPIN. Protein Pept Lett. 2024;31(7):544\u201358.","journal-title":"Protein Pept Lett"},{"issue":"4","key":"3709_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2025.153098","volume":"230","author":"Y Gu","year":"2025","unstructured":"Gu Y, Jia H, Lin X, Wang L. Serum LINC01278 serves as a negative biomarker for sepsis and its up-regulation inhibits LPS-induced inflammatory response in THP-1 cells. Immunobiology. 2025;230(4):153098.","journal-title":"Immunobiology"},{"issue":"3","key":"3709_CR24","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2174\/1573412919666221223152915","volume":"19","author":"L Zhang","year":"2023","unstructured":"Zhang L, Yang H, Liu J, Wang K, Cai X, Xiao W, et al. Metabolomics-based approach to analyze the therapeutic targets and metabolites of a synovitis ointment for knee osteoarthritis. Curr Pharm Anal. 2023;19(3):222\u201334.","journal-title":"Curr Pharm Anal"},{"issue":"5","key":"3709_CR25","doi-asserted-by":"publisher","first-page":"307","DOI":"10.2174\/0113892029255941231014142050","volume":"24","author":"J Qiu","year":"2023","unstructured":"Qiu J, Zhou T, Wang D, Hong W, Qian D, Meng X, et al. Pan-cancer analysis identifies AIMP2 as a potential biomarker for breast cancer. Curr Genom. 2023;24(5):307\u201329.","journal-title":"Curr Genom"},{"issue":"5","key":"3709_CR26","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2174\/1566523222666220825110147","volume":"24","author":"C Liu","year":"2024","unstructured":"Liu C, Shi J, Lin B, Zhou M, Shan D, Nie J, et al. SHR6390 combined with cabozantinib inhibits tumor progression in the hepatocellular carcinoma mouse model. Curr Gene Ther. 2024;24(5):453\u201364.","journal-title":"Curr Gene Ther"},{"issue":"2","key":"3709_CR27","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2174\/0115665232258527230919071328","volume":"24","author":"Y Ning","year":"2024","unstructured":"Ning Y, Zhou X, Wang G, Zhang L, Wang J. Exosome miR-30a-5p regulates glomerular endothelial cells\u2019 endMT and angiogenesis by modulating Notch1\/VEGF signaling pathway. Curr Gene Ther. 2024;24(2):159\u201377.","journal-title":"Curr Gene Ther"},{"issue":"5","key":"3709_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.238","volume":"3","author":"D Chen","year":"2024","unstructured":"Chen D, Xu L, Xing H, Shen W, Song Z, Li H, et al. Sangerbox 2: enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. iMeta. 2024;3(5):e238.","journal-title":"iMeta"},{"issue":"6","key":"3709_CR29","doi-asserted-by":"publisher","first-page":"635","DOI":"10.32604\/chd.2025.056641","volume":"19","author":"H Uma","year":"2024","unstructured":"Uma H, Aminu A, Cherukupalli R, Akintomide F-A, Habu A, Lawal A-A, et al. Case report: Laubry-Pezzi syndrome: confronting the lethal nexus of life-threatening complications in resource constrained settings. Congenit Heart Dis. 2024;19(6):635\u201345.","journal-title":"Congenit Heart Dis"},{"key":"3709_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.956448","volume":"13","author":"N Wang","year":"2022","unstructured":"Wang N, Lu Y, Zheng J, Liu X. Of mice and men: laboratory murine models for recapitulating the immunosuppression of human sepsis. Front Immunol. 2022;13:956448.","journal-title":"Front Immunol"},{"issue":"1","key":"3709_CR31","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","volume":"16","author":"NL Stanski","year":"2020","unstructured":"Stanski NL, Wong HR. Prognostic and predictive enrichment in sepsis. Nat Rev Nephrol. 2020;16(1):20\u201331.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"3709_CR32","doi-asserted-by":"publisher","first-page":"12","DOI":"10.2174\/0113892029272497240103052359","volume":"25","author":"BA Alsayed","year":"2024","unstructured":"Alsayed BA, Mir R, Mir MM, Alnour TMS, Fawzy S, Ahmed MM, et al. Molecular determination of tumor necrosis factor-alpha, interleukin-8, interleukin-10, and C-X-C chemokine receptor-2 genetic variations and their association with disease susceptibility and mortality in COVID-19 patients. Curr Genomics. 2024;25(1):12\u201325.","journal-title":"Curr Genomics"},{"issue":"9","key":"3709_CR33","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1084\/jem.20161427","volume":"214","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Ma CA, Lawrence MG, Break TJ, O\u2019Connell MP, Lyons JJ, et al. PD-L1 up-regulation restrains Th17 cell differentiation in STAT3 loss- and STAT1 gain-of-function patients. J Exp Med. 2017;214(9):2523\u201333.","journal-title":"J Exp Med"},{"key":"3709_CR34","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.3389\/fimmu.2020.01364","volume":"11","author":"MD Martin","year":"2020","unstructured":"Martin MD, Badovinac VP, Griffith TS. CD4 T cell responses and the sepsis-induced immunoparalysis state. Front Immunol. 2020;11:1364.","journal-title":"Front Immunol"},{"issue":"6","key":"3709_CR35","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1002\/ijc.32781","volume":"146","author":"N Ryan","year":"2020","unstructured":"Ryan N, Anderson K, Volpedo G, Hamza O, Varikuti S, Satoskar AR, et al. STAT1 inhibits T-cell exhaustion and myeloid derived suppressor cell accumulation to promote antitumor immune responses in head and neck squamous cell carcinoma. Int J Cancer. 2020;146(6):1717\u201329.","journal-title":"Int J Cancer"},{"issue":"3","key":"3709_CR36","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.immuni.2024.01.019","volume":"57","author":"R Ding","year":"2024","unstructured":"Ding R, Yu X, Hu Z, Dong Y, Huang H, Zhang Y, et al. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells. Immunity. 2024;57(3):528-540.e6.","journal-title":"Immunity"},{"issue":"1","key":"3709_CR37","doi-asserted-by":"publisher","DOI":"10.4110\/in.2025.25.e11","volume":"25","author":"JR Mattingly","year":"2025","unstructured":"Mattingly JR, Wu A, York AG. Regulation of adaptive immunity by lipid post-translational modifications. Immune Netw. 2025;25(1):e11.","journal-title":"Immune Netw"},{"issue":"1","key":"3709_CR38","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/s41419-025-07714-w","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Zhang H, Miao C. Unraveling immunosenescence in sepsis: from cellular mechanisms to therapeutics. Cell Death Dis. 2025;16(1):393.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3709_CR39","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1186\/s12885-025-14096-x","volume":"25","author":"J Yuan","year":"2025","unstructured":"Yuan J, Xu B, Su Y, Zhang P, Zhang X, Gong P. Identification of USP39 as a prognostic and predictive biomarker for determining the response to immunotherapy in pancreatic cancer. BMC Cancer. 2025;25(1):758.","journal-title":"BMC Cancer"},{"issue":"1","key":"3709_CR40","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1615\/CritRevImmunol.2013006721","volume":"33","author":"SA Condotta","year":"2013","unstructured":"Condotta SA, Cabrera-Perez J, Badovinac VP, Griffith TS. T-cell-mediated immunity and the role of TRAIL in sepsis-induced immunosuppression. Crit Rev Immunol. 2013;33(1):23\u201340.","journal-title":"Crit Rev Immunol"},{"key":"3709_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.molimm.2021.04.005","volume":"136","author":"DL Gupta","year":"2021","unstructured":"Gupta DL, Sharma A, Soni KD, Kazim SN, Bhoi S, Rao DN. Changes in the behaviour of monocyte subsets in acute post-traumatic sepsis patients. Mol Immunol. 2021;136:65\u201372.","journal-title":"Mol Immunol"},{"issue":"5","key":"3709_CR42","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1007\/s12026-022-09302-y","volume":"70","author":"M Derigs","year":"2022","unstructured":"Derigs M, Heers H, Lingelbach S, Hofmann R, H\u00e4nze J. Soluble PD-L1 in blood correlates positively with neutrophil and negatively with lymphocyte mRNA markers and implies adverse sepsis outcome. Immunol Res. 2022;70(5):698\u2013707.","journal-title":"Immunol Res"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03709-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03709-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03709-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:52:02Z","timestamp":1770123122000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03709-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3709"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03709-7","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study because it is not involved in any human experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"198"}}